Volcano Corp (NASDAQ:VOLC)

CAPS Rating: 2 out of 5

The Company is engages in the development, manufacture and commercialization of intravascular ultrasound and functional measurement products that are used for the diagnosis and treatment of vascular and structural heart disease.

Recs

0
Player Avatar fxschlump (39.92) Submitted: 1/16/2008 4:38:00 PM : Outperform Start Price: $13.97 VOLC Score: +105.47

This co is working on some new products which will address ovesity, one of our major medical problems in the US--and the world.

Featured Broker Partners


Advertisement